SONN

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Sonnet Biotherapeutics Holdings Inc

NASDAQ | SONN

4.73

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 24, 2025)

$30.31M

Market Cap

-

P/E Ratio

-6.82

EPS

$10.38

52 Week High

$1.08

52 Week Low

HEALTHCARE

Sector

SONN Chart

Recent Chart
Price Action

SONN Technicals

Tags:

SONN Earnings

Yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit $19K
Total Revenue $19K
Cost Of Revenue $83K
Costof Goods And Services Sold $83K
Operating Income -$12M
Selling General And Administrative $6.1M
Research And Development $5.7M
Operating Expenses $12M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $83K
Income Before Tax -$7.4M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$7.4M
Comprehensive Income Net Of Tax -
Ebit -$12M
Ebitda -$12M
Net Income -$7.4M

Revenue & Profitability

Earnings Performance

SONN Financials

yearly Balance Sheet (As of Sep 30, 2024)

Field Value (USD)
Total Assets $2.8M
Total Current Assets $2.1M
Cash And Cash Equivalents At Carrying Value $149K
Cash And Short Term Investments $149K
Inventory -
Current Net Receivables $762K
Total Non Current Assets $653K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.2M
Other Non Current Assets -
Total Liabilities $3.3M
Total Current Liabilities $3.2M
Current Accounts Payable $2.2M
Deferred Revenue -
Current Debt -
Short Term Debt $169K
Total Non Current Liabilities $47K
Capital Lease Obligations $131K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $131K
Other Current Liabilities $858K
Other Non Current Liabilities -
Total Shareholder Equity -$486K
Treasury Stock -
Retained Earnings -$118M
Common Stock $65
Common Stock Shares Outstanding $655K

yearly Cash Flow (As of Sep 30, 2024)

Field Value (USD)
Operating Cashflow -$8.6M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $83K
Capital Expenditures $3
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$12K
Cashflow From Financing $6.5M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$7.4M

yearly Income Statement (As of Sep 30, 2024)

Field Value (USD)
Gross Profit $19K
Total Revenue $19K
Cost Of Revenue $83K
Costof Goods And Services Sold $83K
Operating Income -$12M
Selling General And Administrative $6.1M
Research And Development $5.7M
Operating Expenses $12M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $83K
Income Before Tax -$7.4M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$7.4M
Comprehensive Income Net Of Tax -
Ebit -$12M
Ebitda -$12M
Net Income -$7.4M

SONN News

SONN Profile

Sonnet Biotherapeutics Holdings Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Sonnet Biotherapeutics Holdings Inc. is a cutting-edge biotechnology company headquartered in Princeton, New Jersey, specializing in the development of novel oncological therapies through its proprietary platform for single-acting and bispecific biologics. By harnessing advanced technology, Sonnet is committed to creating targeted treatments that effectively address significant unmet medical needs in cancer care. With a strategic focus on next-generation biologics, the company is poised to lead transformative changes in treatment paradigms, ultimately enhancing patient outcomes in oncology.

WGRX
+247.48%
$1.40
YYAI
-15.73%
$0.07
BYND
+8.08%
$3.06
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
VIVK
+25.55%
$0.32
YDKG
-19.77%
$0.05
BITF
+5.71%
$4.16
WTO
-7.04%
$0.06
INTC
+3.35%
$39.44
AREB
+75.34%
$3.77
NEUP
+52.46%
$6.17
AXDX
-61.36%
$0.03
ADTX
+2.70%
$0.30
VZ
-3.51%
$38.40
BURU
+3.07%
$0.35
NVDA
+1.42%
$184.75
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
QLGN
+44.75%
$5.11
SCNX
-35.00%
$1.69
GPUS
-0.28%
$0.38
TSLA
-2.28%
$438.71
SRM
+53.27%
$10.30
QBTS
+6.66%
$33.12
AMZN
+1.44%
$221.09
AMD
+7.54%
$252.72
AAL
+6.45%
$13.59
CUTR
-10.19%
$0.09
DVLT
+15.10%
$2.58
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
ETWO
0.00%
$3.30
RIG
+4.11%
$4.05
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
KDLY
+10.41%
$0.79
BMNR
+2.41%
$49.19
NOK
+0.32%
$6.18
F
+7.20%
$13.22
RANI
-13.45%
$2.09
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
KLG
-9.05%
$13.35
RGTI
+7.39%
$42.52
GRYP
-10.38%
$1.38
CAN
+4.26%
$1.83
MODV
-25.22%
$0.43
LXEH
+24.60%
$0.56
AIRE
-13.94%
$0.84
OKLO
+3.81%
$124.70
ASST
+10.78%
$0.86
IBM
-0.87%
$285.00
EOSE
-4.64%
$14.36
NRXS
-7.72%
$3.52
AMC
-1.46%
$2.69
NBIS
+7.64%
$106.16
LAES
+2.70%
$5.87
PLTR
+2.45%
$184.91
GNTA
+86.06%
$6.01
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
IONZ
-9.04%
$3.62
ZAPP
-46.30%
$0.15
CIFR
+12.19%
$19.36
PLUG
+3.77%
$2.98
HOOD
+2.75%
$138.02
KDP
+0.58%
$27.55
NGD
+0.62%
$6.46
NUAI
+18.73%
$4.69
BAC
+1.63%
$52.60
DNN
+1.09%
$2.76
WMT
-0.26%
$106.86
NIO
-0.21%
$6.87
IAG
-0.08%
$12.04
RXRX
+0.61%
$5.76
NEHC
+4.22%
$3.95
QS
+2.69%
$15.05
ADAP
+0.85%
$0.07
BREA
+36.64%
$11.41
RR
+5.53%
$5.72
ABEV
+0.67%
$2.22
SMR
+3.72%
$38.95
MSAI
-46.40%
$0.72
SOC
+18.61%
$14.02
ACHR
+3.22%
$11.26
BBD
-0.14%
$3.34
TLRY
+0.76%
$1.49
TGB
+5.15%
$4.08
RVPH
+7.10%
$0.60
ADVM
+3.82%
$4.34
MU
+4.65%
$216.33
IMG
+3.79%
$0.23
DEFT
-1.47%
$2.00
UUUU
+0.23%
$21.31
ONDS
+9.27%
$7.71
CAG
-1.65%
$18.47
T
+0.52%
$24.74
HTZ
+4.84%
$5.19
BP
+1.98%
$35.00
WGRX
+247.48%
$1.40
YYAI
-15.73%
$0.07
BYND
+8.08%
$3.06
CGBS
-39.47%
$0.03
VHAI
0.00%
$0.00
VIVK
+25.55%
$0.32
YDKG
-19.77%
$0.05
BITF
+5.71%
$4.16
WTO
-7.04%
$0.06
INTC
+3.35%
$39.44
AREB
+75.34%
$3.77
NEUP
+52.46%
$6.17
AXDX
-61.36%
$0.03
ADTX
+2.70%
$0.30
VZ
-3.51%
$38.40
BURU
+3.07%
$0.35
NVDA
+1.42%
$184.75
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
QLGN
+44.75%
$5.11
SCNX
-35.00%
$1.69
GPUS
-0.28%
$0.38
TSLA
-2.28%
$438.71
SRM
+53.27%
$10.30
QBTS
+6.66%
$33.12
AMZN
+1.44%
$221.09
AMD
+7.54%
$252.72
AAL
+6.45%
$13.59
CUTR
-10.19%
$0.09
DVLT
+15.10%
$2.58
WLGS
-5.57%
$0.04
SOUN
+2.70%
$18.23
ETWO
0.00%
$3.30
RIG
+4.11%
$4.05
AFMD
-34.94%
$0.18
NCLH
-0.63%
$23.48
KDLY
+10.41%
$0.79
BMNR
+2.41%
$49.19
NOK
+0.32%
$6.18
F
+7.20%
$13.22
RANI
-13.45%
$2.09
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
KLG
-9.05%
$13.35
RGTI
+7.39%
$42.52
GRYP
-10.38%
$1.38
CAN
+4.26%
$1.83
MODV
-25.22%
$0.43
LXEH
+24.60%
$0.56
AIRE
-13.94%
$0.84
OKLO
+3.81%
$124.70
ASST
+10.78%
$0.86
IBM
-0.87%
$285.00
EOSE
-4.64%
$14.36
NRXS
-7.72%
$3.52
AMC
-1.46%
$2.69
NBIS
+7.64%
$106.16
LAES
+2.70%
$5.87
PLTR
+2.45%
$184.91
GNTA
+86.06%
$6.01
SAND
-6.04%
$12.12
SHOT
-74.37%
$0.39
IONZ
-9.04%
$3.62
ZAPP
-46.30%
$0.15
CIFR
+12.19%
$19.36
PLUG
+3.77%
$2.98
HOOD
+2.75%
$138.02
KDP
+0.58%
$27.55
NGD
+0.62%
$6.46
NUAI
+18.73%
$4.69
BAC
+1.63%
$52.60
DNN
+1.09%
$2.76
WMT
-0.26%
$106.86
NIO
-0.21%
$6.87
IAG
-0.08%
$12.04
RXRX
+0.61%
$5.76
NEHC
+4.22%
$3.95
QS
+2.69%
$15.05
ADAP
+0.85%
$0.07
BREA
+36.64%
$11.41
RR
+5.53%
$5.72
ABEV
+0.67%
$2.22
SMR
+3.72%
$38.95
MSAI
-46.40%
$0.72
SOC
+18.61%
$14.02
ACHR
+3.22%
$11.26
BBD
-0.14%
$3.34
TLRY
+0.76%
$1.49
TGB
+5.15%
$4.08
RVPH
+7.10%
$0.60
ADVM
+3.82%
$4.34
MU
+4.65%
$216.33
IMG
+3.79%
$0.23
DEFT
-1.47%
$2.00
UUUU
+0.23%
$21.31
ONDS
+9.27%
$7.71
CAG
-1.65%
$18.47
T
+0.52%
$24.74
HTZ
+4.84%
$5.19
BP
+1.98%
$35.00
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.